Case Report: Reversible Neurotoxicity and a Clinical Response Induced by BCMA-Directed Chimeric Antigen Receptor T Cells Against Multiple Myeloma With Central Nervous System Involvement.
Front Immunol
; 12: 552429, 2021.
Article
en En
| MEDLINE
| ID: mdl-33717057
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Inmunoterapia Adoptiva
/
Neoplasias del Sistema Nervioso Central
/
Síndromes de Neurotoxicidad
/
Mieloma Múltiple
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Límite:
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2021
Tipo del documento:
Article